Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Donata Casadei Giunchi"'
Autor:
Andrea Rocca, Pietro Cortesi, Laura Cortesi, Lorenzo Gianni, Federica Matteucci, Lorenzo Fantini, Antonio Maestri, Donata Casadei Giunchi, Luigi Cavanna, Rosa Ciani, Fabio Falcini, Antonella Bagni, Elena Meldoli, Monia Dall’Agata, Roberta Volpi, Daniele Andreis, Oriana Nanni, Annalisa Curcio, Leonardo Lucchi, Dino Amadori, Anna Fedeli
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: The aim of this study was to improve activity over single human epidermal growth factor receptor 2 (HER2)-blockade sequential neaodjuvant regimens for HER2-positive breast cancer, by exploiting the concomitant administration of trastuzuma
Externí odkaz:
https://doaj.org/article/80cb6bee9a8f421483a798d7d407304c
Autor:
Oriana Nanni, Rosa Ciani, Lorenzo Gianni, Donata Casadei Giunchi, Antonella Bagni, Luigi Cavanna, Laura Cortesi, Federica Matteucci, Annalisa Curcio, Andrea Rocca, Elena Meldoli, Antonio Maestri, Dino Amadori, Daniele Andreis, Pietro Cortesi, Anna Fedeli, Leonardo Lucchi, Roberta Volpi, Fabio Falcini, Lorenzo Fantini, Monia Dall'Agata
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: The aim of this study was to improve activity over single human epidermal growth factor receptor 2 (HER2)-blockade sequential neaodjuvant regimens for HER2-positive breast cancer, by exploiting the concomitant administration of trastuzuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac9c518763b986bcdd4482da09259d76
https://journals.sagepub.com/doi/10.1177/1758835920985632
https://journals.sagepub.com/doi/10.1177/1758835920985632
Autor:
Stefano Luzi Fedeli, Davide Perroni, Andrea Rossi, Oriana Nanni, Dino Amadori, Angelo Gambi, Annalisa Volpi, Donata Casadei Giunchi, Maurizio Marangolo, Emanuela Scarpi, Lorenzo Livi, Rosella Silvestrini, Alberto Ravaioli, Aldo Becciolini
Publikováno v:
Breast Cancer Research and Treatment. 108:259-264
The randomized multicenter study on rapidly proliferating breast cancer, assessed according to thymidine labelling index (TLI), was activated at the end of the 1980s. The present work investigated whether and to what degree the short-term advantages
Autor:
Laura, Medri, Annalisa, Volpi, Oriana, Nanni, Anna Maria, Vecci, Annita, Mangia, Francesco, Schittulli, Franco, Padovani, Donata Casadei, Giunchi, Alfredo, Zito, Alfredo, Vito, Dino, Amadori, Angelo, Paradiso, Rosella, Silvestrini
Publikováno v:
Modern Pathology. 16:1067-1075
The prognostic relevance of mitotic activity was analyzed in a series of 306 patients with node-negative breast cancer treated with locoregional therapy alone, until early relapse. Mitotic activity was evaluated as the number of mitotic figures per 1
Autor:
Monica Ricci, Piero Sismondi, Sara Bravaccini, Luigi Serra, Anita Mangia, Dino Amadori, Maurizio Puccetti, Nicoletta Biglia, Serenella Cerasoli, Roberta Maltoni, S. Petroni, Andrea Rocca, M. Brandi, Angelo Paradiso, Laura Medri, Lorenzo Gianni, Donata Casadei Giunchi, Rosella Silvestrini, Amelia Tienghi, Emanuela Scarpi, Marina Faedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92551ae8b1e92aa909980d2f19543f90
http://hdl.handle.net/2318/145134
http://hdl.handle.net/2318/145134
Autor:
Andrea, Rocca, Sara, Bravaccini, Emanuela, Scarpi, Anita, Mangia, Stella, Petroni, Maurizio, Puccetti, Laura, Medri, Luigi, Serra, Monica, Ricci, Serenella, Cerasoli, Nicoletta, Biglia, Roberta, Maltoni, Donata Casadei, Giunchi, Lorenzo, Gianni, Amelia, Tienghi, Mario, Brandi, Marina, Faedi, Monica, Faedi, Piero, Sismondi, Angelo, Paradiso, Rosella, Silvestrini, Dino, Amadori
Publikováno v:
Breast cancer research and treatment. 144(2)
There are no validated predictors of benefit from anthracyclines. We compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF), and epirubicin in different sequences with CMF alone in a phase III trial on operable breast cancers. Outcomes were an
Autor:
Aldo Becciolini, Angelo Gambi, Davide Perroni, Amelia Tienghi, Paolo Pacini, Donata Casadei Giunchi, Emanuela Scarpi, Dino Amadori, Oriana Nanni, Giuseppina Catalano, Annalisa Volpi, Maurizio Marangolo, Andrea Rossi, Alberto Ravaioli
Publikováno v:
Europe PubMed Central
PURPOSE: According to one of the most recent key scientific questions concerning the use of biomarkers in clinical trials, we investigated whether node-negative breast cancer patients, defined as high-risk cases on the basis of tumor cell proliferati
Autor:
Donata Casadei Giunchi, Wainer Zoli, Monica Dal Susino, F. Barzanti, Carlo Milri, L. Ricotti, Dino Amadori, Giovanni Luca Frassineti
Publikováno v:
International Journal of Cancer. 80:413-416
We showed previously that a sequential treatment with doxorubicin (4 hr) followed by paclitaxel (24 hr) (DoxPacl) induces a synergistic cytotoxic effect in the BRC-230 breast cancer cell line and in human primary breast cancer cultures. The validity
Autor:
Luca Saragoni, Carlo Naldoni, Lauro Bucchi, Oriana Nanni, Stefania Giorgetti, Patrizia Gentilini, Donata Casadei Giunchi, Giuseppe Lanzanova, Giorgio Gambi, Carlo Milandri, Carlo Cordaro, Dino Amadori, Gian Enea Zarabini, Anselmo Piatesi, Paolo Lorenzini, Marina Marchini, Gianfranco Buzzi, Silvia Salvatore, Mirella Aldi, Fabio Falcini, Ruggero Ridolfi, Giorgio Cruciani, Flavia Foglietta, Rosa Vattiato, Monica Serafini, Patrizia Bravetti, Manuela Montanari
Publikováno v:
Cancer. 80:1432-1437
Autor:
Amadori A, Laura Amaducci, Donata Casadei Giunchi, Roberta Maltoni, Annalisa Volpi, Rosella Silvestrini, Dino Amadori, Ariele Saragoni, Antonio Vio, Oriana Nanni
Publikováno v:
Breast Cancer Research and Treatment. 43:7-14
Many biologic prognostic markers are available for patients with breast cancer, and considerable interest has been devoted to confirm preliminary evidence of their role as indicators of treatment response. It remains to be assessed whether such marke